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INTRODUCTION
The airway mucosa is under constant attack from invading pathogens, which are recognised by pattern recognition receptors (PRR) on the surface of airway epithelial cells and circulating immune cells. Toll-like receptor 4 (TLR4) recognises the LPS component of Gram-negative bacterial cell walls. Activation of TLR4 triggers an innate immune response leading to an acute inflammatory response that is largely mediated by the transcription factor NF-B. Following receptor-ligand binding with the plasma membrane, the intracellular stages of the NF-B signalling cascade are tightly regulated to ensure timely termination of the inflammatory response. A20 (TNFAIP3, (tumour necrosis factor, alpha-induced protein 3)) is an endogenous negative regulator of NF-B signalling that is rapidly and transiently induced in response to bacterial and viral stimuli. A20 terminates NF-κB driven inflammation in response to LPS by inhibiting the polyubiquitination and activation of the central adaptor protein TNF receptor-associated factor (TRAF)6 (Lin et al. 2008 ).
In the lung, Gram-negative Pseudomonas aeruginosa (P. aeruginosa) challenge rapidly induces A20 in mice (Tiesset et al. 2009 ), while A20 is essential for termination of TLR2/4 mediated IL-8 release from primary airway epithelial cells (Gon et al. 2004 ).
Furthermore, A20 protects against ovalbumin (OVA)-induced 'asthma' in mice (Kang et al. 2009 ). Li et al. (2013) showed that A20 is involved in antigen degradation by facilitating the fusion between the endosome and lysosome, resulting in reduced antigenicity upon absorption of the antigen. We recently demonstrated that A20 is significantly reduced in the chronically inflamed Cystic Fibrosis (CF) airway epithelium and that basal mRNA expression correlates strongly with lung function (FEV1 % predicted) in people with CF (Kelly et al. 2013a (Kelly et al. , 2013b . In addition to observations in the airways, A20 is known to be important in the pathogenesis of various inflammatory diseases (rheumatoid arthritis, systemic lupus erythematosus, Type 1 Diabetes, multiple sclerosis, psoriasis, colitis, chronic inflammatory bowel disease and Crohn's disease), where it may also serve as a susceptibility gene and biomarker of disease development (Martin and Dixit 2011 , Barmada et al. 2004 , Wellcome Trust Case Consortium 2007 . A20 knockout in epithelial cells promotes severe mucosal inflammation (Vereecke et al. 2011) . The therapeutic potential of targeting the A20 gene and resulting protein has been widely recognized but a therapeutic agent is not currently available.
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Although a critical regulator of mammalian immune responses, A20-like zinc finger proteins are also important in controlling plant stress responses. Liu et al. reported that gibberellic acid (GA3), a tetracyclic diterpene, induces A20-like zinc finger proteins in rice crops (Liu et al. 2011) . Interestingly, GA3 has previously been used in the treatment of human lung cancer and in a rodent model of diabetes, and was shown to exert anti-inflammatory and analgesic effects (Miklussak et al. 1980, Muthuraman and Srikumar 2009 ). Furthermore, a recently developed gibberellin derivative possesses potent anti-tumor and anti-angiogenic activity in various tumour derived cell lines (Zhang et al. 2012 Furthermore, most terpenes inhibit NF-κB activity, although the precise mechanisms of action have not been fully characterized. In particular, forskolin has been used successfully in the treatment of asthma to reduce inflammation and histamine release through activation of cAMP-dependent mechanisms (Huerta et al. 2010 ). In the case of kaurenes, Castrillo et al. (2001) have identified relevant targets for this inhibition, showing that the inhibition of NIK (NF-κB inducing kinase, non-canonical NF-B pathway) and p38 and/or ERK1 and ERK2 activation abrogates the inflammatory response, of genes dependent on NF-κB activation in particular. The fact that kaurenes are intermediates in the biosynthesis of plant hormones, such as gibberellins, offers the possibility of envisaging further analysis of the interaction of these molecules in several aspects of mammalian cell biology (Castrillo et al. 2001) .
Several gibberellin-based preparations are under patent for the treatment of diabetes (Patent reference US 20050215496 A1), psoriasis and prostatitis (Patent reference WO 1991008751 A1), highlighting the increasing interest in developing gibberellins for preclinical and clinical trials. However, gibberellins have not yet been used clinically as antiinflammatory drugs and the mechanism of action has not been reported. Here, we seek to investigate if GA3 can induce A20 and thereby reduce the innate inflammatory response to bacterial LPS in airway epithelial cells (16HBE14o-and primary nasal epithelial cells).
EXPERIMENTAL PROCEDURES

Cell Culture
The immortalised bronchial epithelial cell line 16HBE14o-(obtained from D. Gruenert UCSF, USA) was grown as described (Kelly et al. 2013c) . Primary nasal epithelial cells (NEC) were obtained from healthy volunteers (n=7) and grown as previously described (de Courcey et al. 2012) . The participants did not have any acute airways disease at the time of sampling, or a history of any chronic airways inflammation. The study was approved by the Research Ethics Committee of Northern Ireland (07/NIR02/23) and all participants provided informed consent (de Courcey et al. 2012) .
Cell culture stimulations
All cells were treated with LPS (P. aeruginosa, Sigma-Aldrich, 10 g/ml) for up to 24 h. Cells were exposed to a range of GA3 concentrations (Sigma-Aldrich, G7645, lot BCBB9751, 3-300 µM) or dexamethasone (Dex, Sigma-Aldrich, D4902, lot BCBH2988V, 1 µM) for 1 h prior to LPS stimulation.
Determination of LPS induced cytokine release (IL-6 and IL-8)
The concentrations of IL-6 and IL-8 in cell-free culture supernatants were measured by a commercially available ELISA (PeproTech EC Ltd., UK) according to the manufacturer's instructions.
LDH Cytotoxicity assay
The effect of GA3 on membrane integrity was determined by quantification of lactate dehydrogenase (LDH) in cell culture supernatants (LDH-Cytotoxicity Assay Kit, BioVision
Ltd. USA) according to the manufacturer's instructions.
Proliferation Assay
Cell proliferation was determined using the CellTiter 96® AQueous One Solution Cell
Proliferation Assay (Promega, UK) following 72h exposure to GA3 and according to the manufacturer's recommendations. The assay determines the activity of mitochondrial NAD(P)H-dependent oxidoreductases, which reduces the tetrazolium dye MTS (3-(4,5-di-methylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) to insoluble purple formazan, which is measured at =490 nm.
Transfection studies
Transfections were performed at 70-80% confluency. A20 was silenced in 16HBE14o-cells using a commercially available human A20 siRNA (GenomeWide siRNA, Qiagen) and
RNAiFect™ Transfection Reagent (Qiagen). Experiments included mock (transfection reagent only) and scrambled (Allstars Neg siRNA, Qiagen) controls. A20 knockdown was confirmed by qPCR (transfection efficiency over 70%) and Western Blot.
RNA extraction and real time qPCR
Total RNA was extracted using an RNeasy kit (Qiagen) and quantified on a Nanodrop Expression of A20, p65 and -actin (housekeeping gene) were assessed by qPCR. All primer sequences are given in Table S1 . Relative expression to β-actin was calculated using the ΔΔCt method. To overcome inter-patient variability in basal gene expression levels in NECs, mRNA expression after LPS stimulation (24h) was compared with mRNA expression at 0h (standardized to 1) for each individual sample. cDNA obtained from Jurkat cells acted as an internal calibrator for all experiments and was used to determine differences in basal gene expression.
Western Blotting
Protein expression was determined by Western Blotting after extraction of total proteins in RIPA buffer. Cell lysates were diluted in nuclease free water and Laemmli loading buffer, loaded onto Tris-HCl polyacrylamide gels (Thermo Scientific), separated by SDS-PAGE and transferred to a PVDF membrane. Membranes were incubated with 1 µg/ml primary antibodies (Ber-A20 (Hirsch et al. 2012 ), A20 C-terminal (IMGENEX, IMG-161A), p65 9 (Santa Cruz Biotechnology, C-20), IkB (Santa Cruz Biotechnology, C-21) washed, incubated with appropriate horseradish peroxidase-conjugated secondary antibodies (Thermo Scientific, UK) and visualized on a BioRadChemi Doc XRS system.
P65 activation ELISA
Nuclear protein was extracted from 16HBE14o-cells using the Ne-Per™ assay (Thermo Scientific, cat no.78833). Total protein was determined in the extracts using the BCA protein assay (Pierce, cat no. 23225) and equal amounts nuclear protein (10 g) were used in the p65 activation ELISA (Activ Motif, TransAM ® , NF-B Family Transcription factor Assay kit, Cat no. 43296). Briefly, each ELISA well contains the immobilized NF-B consensus site (5'-GGGACTTTCC-3') to which active NF-κB binds. The primary antibody (here anti-p65)
can only bind to the epitope on the active p65 that is bound to its target DNA. Then an HRPconjugated secondary antibody is used to provide a sensitive colorimetric readout that is sprectrophotometrically quantified. All assays were performed according to the manufacturer's instructions.
Statistical analysis
All data are presented as the means ± SEM. Differences between groups were analysed using the Kruskal-Wallis non-parametric ANOVA, which was considered to be significant if p < 0.05. Dunn's post-test was performed if the Kruskal Wallis test was significant. To assess the effect of GA3 pre-treatment on LPS stimulated PNECs, Willcoxon paired T-test was applied. Statistical significance levels are indicated as *p<0.05, **p<0.01 and ***p<0.001.
GraphPad Prism was used to plot graphs and to analyse the data.
RESULTS
Changes in gene or protein expression are shown relative to the corresponding untreated control. Given the limited amount of material available from primary cultures, all primary NEC investigations were performed at the mRNA level initially and confirmed at the protein level where possible.
Effect of GA3 pre-treatment on cellular viability and LPS-stimulated cytokine release
In the first instance, we sought to determine an optimal non-cytotoxic GA3 dose that would also induce significant anti-inflammatory effects. Therefore, the effect of various GA3 concentrations (0.03-300 M) on cellular viability and LPS-stimulated IL-6 and IL-8 release was investigated in the bronchial epithelial cell line 16HBE14o-.
LDH release into cell culture supernatants was analysed 24 h after GA3 treatment and used as a measure of cytotoxicity. GA3 concentrations of 0.03-30 M did not increase LDH release above the vehicle control, while 300 M GA3 caused a significant increase in LDH release (p<0.001, n=6; Fig 1A) . IL-8 release was significantly increased compared with untreated cells following 24 h LPS stimulation ( Fig 1B) . In 16HBE14o-cells, GA3 treatment alone did not have any effect on basal IL-8 release, but GA3 pre-treatment significantly reduced the LPS-induced IL-8 release in a dose-dependent manner with a significant reduction at 30 M (p<0.01, n=5-9) ( Fig 1B) . The maximal effective concentration to reduce IL-8 was 28.19 M, while a reduction of 40% was achieved at 2.82 M ( Fig 1C) . Similarly, GA3 treatment alone did not have any effect on basal IL-6 release, but GA3 pre-treatment significantly reduced the LPS induced IL-6 release with a significant reduction at 30 M (p<0.05, n=5-8) ( Fig 1D) .
Based on these results and previous publications, a concentration of 30 M GA3 was employed in all further experiments. For comparative purposes, the anti-inflammatory effect of dexamethasone (Dex, 1 µM), was also investigated (Fig 1B, D) . IL-8 and IL-6 release from 16HBE14o-cells pre-treated with Dex prior to LPS stimulation displayed significantly lower levels of each cytokine than cells treated with LPS alone (p<0.001 for both cytokines, n=5) or GA3 and LPS (p<0.05 for both cytokines, n=5).
Our initial experiments in 16HBE14o-cells were confirmed in primary nasal epithelial cells (PNECs). PNECs were pre-treated with GA3 (3-300 M) for 1 h before LPS was added to the cultures for a further 24 h. GA3 concentrations of 0.3-300 M did not increase LDH release above the vehicle control, but 300 M GA3 caused a significant increase in LDH release compared to 0.3 M and 3 M (p<0.01 and p<0.05, respectively, n=6; Fig 2A) . In PNECs, LPS treatment significantly increased IL-8 and IL-6 release (p<0.05 and p<0.01 respectively, n=7), ( Fig 2B-1 and Fig 2C-1) , while GA3 pre-treatment significantly reduced it (p=0.019 and p=0.008, Wilcoxon (paired t-test, n=7) at 24 h ( Fig 2B-2 and Fig 3C-2) .
GA3 promotes an A20-driven, anti-inflammatory response in 16HBE14o-cells
LPS stimulation of 16HBE14o-cells resulted in the rapid and transient induction of A20 mRNA with peak expression observed after 1 h. Thereafter, A20 expression slowly declined and returned to basal levels 4 h after LPS stimulation ( Fig 3A) . This is consistent with the original findings of Opipari et al. (1990) . GA3 pre-treatment (30 M) alone significantly induced A20 mRNA expression compared to culture medium control (1 h, p<0.05). The subsequent addition of LPS further enhanced and prolonged the induction of A20 mRNA compared to culture medium control (1 h and 4 h, p<0.001, 24 h, p<0.05,), LPS alone (4 h, p<0.05) or GA3 alone (1 h and 4 h, p<0.05) and A20 expression remained above basal levels in GA3 pre-treated cells even 24 h after LPS treatment ( Fig 3A, n=5-9 ). A20 mRNA expression was not induced in 16HBE14o-cells treated with Dex, prior to LPS stimulation ( Fig 3A) .
Furthermore, analyses of p65 mRNA expression showed a significant induction of p65 by LPS alone (p<0.001, 4 h vs. Medium Control, n=5-9, Fig 3B) and GA3 pre-treated 16HBE14o-show a significant reduction of LPS-induced p65 (p<0.001, 4 h vs. Medium
Control, n=5-9, Fig 3B) , suggesting that GA3 negatively affects the NF-κB pathway. Pretreatment of 16HBE14o-cells with Dex also attenuated LPS-induced p65 expression;
however, this effect was not significant (Fig 3B) .
To investigate if the observed induction of A20 and the subsequent reduction in p65 by GA3 is responsible for the anti-inflammatory effects outlined in Fig 1B and 2B-1, 16HBE14o-cells were treated with siRNA targeting A20. Fig 3C shows that when A20 is silenced in 16HBE14o-cells, the anti-inflammatory effect of GA3 on LPS-induced IL-8 release is lost (p<0.001, n=5, Fig 3C) . These experiments suggest that GA3 acts in an A20dependent manner.
GA3 induces A20 mRNA and protein in PNECs
To investigate the effect of GA3 on A20 in PNECs, cells were pre-treated with GA3 (30 M)
for 1 h before the addition of LPS to the cultures and incubated for a further 24 h. In nonstimulated cells, A20 mRNA levels remained unchanged over the duration of the experiment (data not shown). When cells were stimulated with LPS for up to 24 h, A20 mRNA levels increased significantly over culture medium control (p<0.01, n=7) with a peak expression at 4 h ( Fig 4A) . GA3 exposure alone induced A20 mRNA in PNECs in a time-dependent manner (p<0.05, 24 h vs. culture medium control, n=7, Fig 4A) . In GA3 pre-treated cells, LPS (10 g/ml) increased A20 mRNA levels significantly over medium control (n=7 with p<0.001 at 4 h and p<0.01 at 24 h). GA3 pre-treated and LPS stimulated PNECs also showed a significant increase in A20 mRNA compared to LPS alone at 4 h (p<0.05, n=7, Fig 4A) . In Dex pre-treated and LPS stimulates 16HBE14o-no significant induction of A20 mRNA was observed n=5). A20 protein expression (24 h after LPS challenge) was determined by
Western Blotting and quantified. In accordance with mRNA levels, A20 protein was induced by GA3 in PNECs challenged with LPS (p<0.05, compared to GA3, n=6, Fig 4B) .
Using an antibody against the C-terminal end of A20 that has been previously used to identify A20 cleavage products (http://www.novusbio.com/primary-antibodies/tnfaip3). We show that GA3-dependent induction of A20 in PNECs results in an up-regulation of the whole A20 protein: The representative blot and the quantification in Fig 4C (n=4) shows Cterminal A20 protein bands with a molecular weight of the expected 80 kD (whole protein) and those with approximately 60 kD and 50 kD corresponding to C-terminal A20 fractions containing zinc finger 1-2 (~50 kD) and zinc finger 1-3 (~60 kD) (Klinkenberg et al. 2001 ).
The antibody also detects a C-terminal A20 fraction of around 40 kD, although bands of this size were not detected in this study. Incubation with GA3 in the presence or absence of LPS leads to an increase of all protein bands in similar proportions ( Fig 4C) . Only in GA3 and LPS treated cells, the 60 kD band, corresponding to zinc finger 1 to 3, was significantly increased compared to control cells (p<0.05, n=4, Fig 4C) .
GA3 reduces LPS induced cytokine release via reduction of NF-κB (p65)
We and others have previously shown that IL-8 production in epithelial cells is largely dependent on p65 activation (Dommisch et al. 2010 , Kelly et al. 2013b ). To investigate if GA3 affects NF-B signalling, p65 mRNA was analysed 1, 4 and 24 h after LPS challenge in GA3 pre-treated PNECs. LPS significantly induced p65 mRNA expression compared to culture medium control at 1 h and 4h (p<0.05 and <0.001, n=7). However, p65 mRNA was significantly reduced in GA3 treated PNECs 4 h after LPS challenge (p<0.05, n=7) ( Fig 5A) .
Dex pre-treatment of PNECs and subsequent LPS stimulation, similar to pre-treatment with GA3, resulted in a significant reduction of p65 mRNA 4h after stimulation (p<0.05, n=5) ( Fig 5A) .
LPS induced NF-B (p65) activation starts with the posttranslational modification e.g. by phosphorylation of p65 (phosphorylation on serine 536), in the cytosol and is then translocated into the nucleus (Hall et al. 2006) . Having shown a reduction of p65 mRNA by GA3 treatment, we further confirmed that GA3 exerts its anti-inflammatory action via modulation of NF-B activation. Firstly, the level of nuclear activated NF-B (p65) was significantly induced by stimulation with LPS at 15 min returning to culture medium control levels at 24h (p<0.001 and p<0.01, n=5, Fig 6A) . GA3 pre-treated and LPS stimulated 16HBE14o-showed significantly reduced nuclear active p65 at 15 min compared to LPS stimulation alone (p<0.05, n=5, Fig 6A) . Dex pre-treatment also reduced p65 activity 15 min after LPS stimulation (p<0.01, n=5, Fig 6A) .
Secondly, phosphorylation of p65 on serine 536 was determined in whole cells (cytosolic and nuclear) extracts in 16HBE14o-by Western Blotting. Our results indicate a reduction of the phosphorylation on serine535 in GA3 pre-treated cells for up to 8 h after LPS challenge ( Fig 6B) .
Finally, we investigated key events in the pathway upstream of p65 in 16HBE14ocells. LPS-mediated activation of NF-B is reliant on the activation and subsequent degradation of IkB We determined cytosolic IB protein expression in PNECs and show that LPS treatment significantly reduces cytosolic IB (p<0.05), while treatment with GA3 restored in part IB protein levels (p=0.05) (all n=6, Fig 6C) .
Overall these results confirm an anti-inflammatory effect of GA3 in LPS stimulated airway epithelial cells. This appears to be mediated, in part at least, by the induction of A20
(mRNA and protein) and subsequent inhibition of key stages in the NF-κB pathway.
DISCUSSION
The cytoplasmic zinc finger protein A20 is a central negative regulator of NF-κB that governs multiple intracellular pathways. Here, we report that pre-incubation of LPSstimulated airway epithelial cells (16HBE14o-cells and PNECs) with GA3, significantly induces A20 mRNA and protein. Although GA3 alone also induced A20 mRNA, this did not result in a detectable increase in protein, suggesting that GA3 mainly enhances LPS-induced A20 expression. Maximal induction of mRNA was slightly delayed in PNECs compared to 16HBE14o-cells (1 h vs. 4 h), which could be explained by the differences in the cell types (16HBE14o-is a SV immortalized cell line (Kelly et al. 2013c) , whereas PNECs are primary cells cultured for up to 3 passages). Furthermore, the induction of A20 was accompanied by a significant increase in IBlevels and subsequent reduction in NF-B expression and IL-6
and IL-8 release in both cell lines and primary epithelial cells. Silencing of A20 confirmed that the reduction in IL-8 release was A20 dependent.
El-Mofty et al. suggested that GA3 had carcinogenic effects and lead to tumour formation in Swiss Albino mice (El-Mofty et al. 1994 ). However, we tested GA3 at a range of concentrations from 0-300 M and found no evidence of cellular toxicity or increased proliferation even at 3 or 30 M (Figure S1 , Supplement). The proliferation assay was conducted over 72 h to ensure at least one complete cell cycle had taken place. In our hands the doubling time of 16HBE14o-cells is approximately 28 h.
Our results are in line with data by Kasamatsu et al. (2012) , who showed that incubating adipose-derived stem cells with GA3 (1 mM) did not alter cell morphology or viability. Early work by Miklussák et al. (1980) suggested that administration significantly improves metabolic functions in patients with lung cancer. More recently, Zhang et al. (2012) showed that the gibberellin derivative 3-chlorine-3,15-dioxy-gibberellic acid methyl ester (GA-13315), possessed potent antitumor and antiangiogenic activity in vitro and in vivo.
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LPS activation of the NF- B pathway is dependent on the ubiquitination and subsequent proteasomal degradation of TRAF6 (Mabilleau et al. 2011) . This process frees bound signalling molecules for subsequent downstream events including the activation of NEMO, degradation of cytosolic IκB and translocation of NF- B subunits to the nucleus.
NF-κB is sequestered in the cytoplasm, bound by members of the IκB family of inhibitor proteins, which includes IκB  . IKK phosphorylates IκB  , resulting in its K48-linked ubiquitination and subsequent proteasomal degradation. This then allows translocation of the NF-κB subunits p65/p50 to the nucleus to activate target genes. To address where GA3 acts in the NF-κB pathway, we show a significant reduction in cytosolic IκB  protein in LPS stimulated cells, suggesting that it has been degraded to release the NF-κB subunits to the nucleus. GA3 treatment inhibits the LPS induced degradation of IκB  , which may explain the anti-inflammatory effect seen (reduced IL-8 and IL-6 release and p65 mRNA). Furthermore, we show that GA3 treatment leads to reduced p65 nuclear activity ( Fig 6A) and this is associated with decreased phosphorylation of p65 on serine 536 ( Fig 6B) .
Information about the induction of A20 is still controversial. A20 has been described as being NF-κB dependent, and da Silva et al. (2012a) showed that this activation of the 'anti-inflammatory arm of NF-κB' is associated with reduced expression of phosphorylated (ser536) p65 compared to the induction of phosphorylated (ser536) p65 by TNFalone.
Similarly, we show here that in bronchial epithelial cells the induction of A20 by GA3 pretreatment leads to a reduction in the expression of phosphorylated (ser536) p65 compared to LPS stimulated cells (Fig. 6B) suggesting that the phosphorylation of p65e.g. by IKK kinases (Hall et al. 2006 )could be a target of A20. Our data on p65 nuclear activity ( Fig.   6A ) may suggest that GA3 itself induces low levels of NF-B (although not statistically significant), but further phosphorylation states or DNA binding sites of p65 would need to be investigated.
Finally, the A20 protein consists of an N-terminal OTU (Ovarian tumour) domain and a C-terminal domain that consists of 7 Cys-Cys zinc fingers. Work by Evans et al. (2004) assigned the DUB (deubiquitination) activity to the OTU domain whereas the antiinflammatory activity was in the zinc finger domain (especially zinc finger 4 and 7 have been identified to exhibit the anti-inflammatory effect of A20 (O'Reilly and Moynagh 2003 , Dommisch et al. 2010 , Tokunaga et al. 2012 ). Furthermore, De Valck et al. (1996) showed that A20 zinc fingers have the ability to self-assemble to build the whole A20 zinc finger domain. To investigate if GA3 can induce the whole A20 protein we used two antibodies against full length A20 and the C-terminal domain specifically (O'Reilly and Moynagh 2003, Dommisch et al. 2010) . Our data suggest that in PNECs, incubation with GA3 in the presence or absence of LPS leads to an increase of all protein bands in similar proportions representing the whole protein and the zinc finger domain of the A20 protein. However, in cells treated with GA3 and LPS the 60 kD fraction appeared to be increased compared to unstimulated cells. The 60 kD band has been described as zinc finger (ZF) 1-3 (~60 kD) (Klinkenberg et al. 2001 ) and our findings are in accordance with the description for this commercial A20 antibody in THP1 cells (http://www.novusbio.com/primary-antibodies/tnfaip3). ZF 4 has been shown to facilitate the NF-B reducing anti-inflammatory action of A20 (Wertz et al. 2004; Lu et al. 2013) , but mice with a non-functional ZF4 showed that this domain might not be needed for the anti-inflammatory function of A20. In T cells MALT1 cleaves A20 into a 37 kD and a 50 kD fraction (McAllister-Lucas and Lucas 2008; Malinverni et al. 2010 ), but to date this 60 kD band has not been further identified.
The current study has some limitations: Firstly, the effect of GA3 on inflammatory mediators and the mechanism of its anti-inflammatory action have been investigated in cell culture, which may also impose several limitations. In most experiments we used an immortalised cell line (16HBE14o-). A characteristic of these cells is that they release IL-8
and IL-6 throughout proliferation. This may explain why cytokine levels are already relatively high in untreated cells. Furthermore, compared to macrophages or monocytic cell lines, relatively high amounts of LPS are needed to stimulate airway epithelial cells and this is true for cell lines and primary cells alike. Another limitation of our study is that the effects of GA3 on p65 and IκBalthough associated with A20 inductionhave not been further validated using siRNA experiments. However, we do show that the anti-inflammatory effect of GA3 is directly dependent on the induction of A20, as GA3 has no effect on the release of inflammatory mediators in cells lacking A20 (knock down of A20 via siRNA, Fig. 3C ). In PNECs, the number of experiments is limited by the low cell number available from nasal brushings and the fact that PNECs can only be expanded up to passage 3. Due to the lack of PNECs our investigation of induction of zinc finger fractions was only performed four times, which may lead to an imperfect statistical estimation. Many products are known to contain trace amounts of LPS and small amounts of LPS may desensitize to a subsequent challenge.
The GA3 preparation used in this study passes the tests for plant cell culture applications (Sigma), but has not been specifically tested for its LPS content. However, determination of TLR4 mRNA in GA3 treated cells shows no change in the expression of TLR4 while in LPS stimulated cells TLR4 shows a time-dependent upregulation (Fig. S2, Supplement) . Overall this may suggest that the GA3 preparation lacks TLR4 stimulating endotoxins. Finally, future work is required to determine if GA3 reduces pro-inflammatory cytokine secretion when cells are treated after LPS challenge.
In summary, we describe that pre-incubation of airway epithelial cell lines and primary nasal epithelial cells with GA3 (single bolus of 30 M) induces the NF-B regulator A20 at mRNA and protein level thereby exerting an anti-inflammatory effect upon subsequent LPS stimulation. Our work provides molecular evidence (i) for A20 as a therapeutic target in inflammatory diseases and (ii) for the plant diterpenoid gibberellin in reducing NF-B driven inflammatory responses. Gibberellin or gibberellin-derived derivatives could be developed into anti-inflammatory drugs for the potential treatment of chronic inflammatory diseases associated with A20 dysfunction such as salivary gland degeneration (Kasamatsu et al. 2012 ), liver degeneration (da Silva et al. 2012b , bone resorption associated with inflammatory diseases (Shimada et al 2008 , Mabilleau et al. 2011 and psoriasis (Gon et al. 2004 , Kelly et al. 2012b ). Furthermore, the concept of pharmacological induction of A20 presents A20 as a potential drug target to reduce or normalise the inflammatory response in chronic inflammatory airway diseases such as CF, asthma and COPD. Further work will investigate GA3 in primary cells from patients with chronic airways disease. For figure B and D: medium control (grey), GA3 (blue), LPS (red), GA3+ LPS (purple), Dex (green)). This effect was significantly attenuated when cells were pre-treated with GA3 [30 μM, 1h] (p<0.001, n=5-9). For figure A and B: medium control (grey), GA3 (blue), LPS (red), GA3+ LPS (purple), Dex (green)). (C) However, when A20 was silenced with siRNA, the antiinflammatory effect of GA3 (determined by IL-8 release of LPS stimulated cells (24 h)) is lost (p<0.001, n=5, Fig 3C) . were pre-treated with GA3 and then challenged with LPS (purple bar) (p<0.05, n=6, over GA3 alone (blue bar)). (C) Representative blot and quantification of Western Blots after use of IMG-161A, an antibody against the C-terminal end of A20 that can identify several zinc fingers. Incubation with GA3 in the presence or absence of LPS leads to an increase of all protein bands in similar proportions with the highest increase in the 50kD (zinc finger 1-2) band compared to medium control or LPS alone. Only in GA3 pre-treated and LPS treated cells the 60 kD band, corresponding to zinc finger 1 to 3, was significantly increased compared to control cells (p<0.05, n=4, Fig 4C) .
FIGURE LEGENDS
Figure 5: GA3 suppresses p65 expression in PNECs
PNECs were treated with LPS alone [10 μg/ml], or pre-treated with GA3 [30 μM, 1 h] or
Dexamethasone [Dex, 1 μM, 1h] prior to the addition of LPS [10 μg/ml] for 1, 4 or 24 h.
LPS-induced p65 expression (mRNA) was subsequently measured by qPCR and found to be significantly reduced in GA3 treated PNECs 4 h after LPS challenge (p<0.05, n=5-7).
Medium control (grey), GA3 (blue), LPS (red), GA3+ LPS (purple), Dex (green)). Medium control (grey), GA3 (blue), LPS (red), GA3+ LPS (purple)).
